| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Durogesic DTrans 25micrograms/hour transdermal patches (CST Pharma Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Durogesic DTrans 100micrograms/hour transdermal patches (CST Pharma Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Durogesic DTrans 50micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Durogesic DTrans 75micrograms/hour transdermal patches (CST Pharma Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Durogesic DTrans 100micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Hydroxycarbamide 100mg tablets 60 tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Durogesic DTrans 25micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Thiopental 500mg powder for solution for injection vials (Advanz Pharma) 10 vial |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Suprasorb H dressing (adhesive) 14cm x 14cm square (Vernon-Carus Ltd) 1 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Suprasorb H dressing (adhesive) 14cm x 14cm square (Vernon-Carus Ltd) 5 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Bemiparin sodium 3,500units/0.2ml solution for injection pre-filled syringes 2 pre-filled disposable injection |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Ultec Pro adhesive dressing 14cm x 14cm square (Tyco Healthcare) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Zibor 3,500units/0.2ml solution for injection pre-filled syringes (Amdipharm) 2 pre-filled disposable injection |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Ultec Pro adhesive dressing 15cm x 18cm sacral (Tyco Healthcare) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Zibor 3,500units/0.2ml solution for injection pre-filled syringes (Amdipharm) 10 pre-filled disposable injection |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Zibor 2,500units/0.2ml solution for injection pre-filled syringes (ROVI Biotech Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Bemiparin sodium 3,500units/0.2ml solution for injection pre-filled syringes 10 pre-filled disposable injection |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Bemiparin sodium 2,500units/0.2ml solution for injection pre-filled syringes 2 pre-filled disposable injection |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| kliniderm Hydrocolloid Border dressing 14cm x 14cm square (H & R Healthcare Ltd) 1 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Versiva dressing 14cm x 14cm square (ConvaTec Ltd) 1 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| kliniderm Hydrocolloid Border dressing 15cm x 18cm sacrum (H & R Healthcare Ltd) 5 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Zibor 3,500units/0.2ml solution for injection pre-filled syringes (Amdipharm) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Zibor 3,500units/0.2ml solution for injection pre-filled syringes (ROVI Biotech Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Hydrocolloid dressing semi-permeable sterile with adhesive border 15cm x 18cm sacral 5 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| CombiDERM dressing 14cm x 14cm square (ConvaTec Ltd) 10 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Ultec Pro adhesive dressing 15cm x 18cm sacral (Tyco Healthcare) 5 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Ultec Pro adhesive dressing 14cm x 14cm square (Tyco Healthcare) 5 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Bemiparin sodium 2,500units/0.2ml solution for injection pre-filled syringes 10 pre-filled disposable injection |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Ultec Pro adhesive dressing 15cm x 18cm sacral (Tyco Healthcare) 1 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| kliniderm Hydrocolloid Border dressing 14cm x 14cm square (H & R Healthcare Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Zibor 2,500units/0.2ml solution for injection pre-filled syringes (Amdipharm) 2 pre-filled disposable injection |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| CombiDERM dressing 14cm x 14cm square (ConvaTec Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Zibor 2,500units/0.2ml solution for injection pre-filled syringes (Amdipharm) 10 pre-filled disposable injection |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Hydrocolloid dressing semi-permeable sterile with adhesive border 14cm x 14cm square 1 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Hydrocolloid dressing semi-permeable sterile with adhesive border 14cm x 14cm square 10 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| kliniderm Hydrocolloid Border dressing 14cm x 14cm square (H & R Healthcare Ltd) 5 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| kliniderm Hydrocolloid Border dressing 15cm x 18cm sacrum (H & R Healthcare Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| kliniderm Hydrocolloid Border dressing 15cm x 18cm sacrum (H & R Healthcare Ltd) 1 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Hydrocolloid dressing semi-permeable sterile with adhesive border 14cm x 14cm square 5 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Zibor 2,500units/0.2ml solution for injection pre-filled syringes (ROVI Biotech Ltd) 10 pre-filled disposable injection 2 x 5 pre-filled syringes |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Versiva dressing 14cm x 14cm square (ConvaTec Ltd) 10 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Hydrocolloid dressing semi-permeable sterile with adhesive border 15cm x 18cm sacral 1 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| CombiDERM dressing 14cm x 14cm square (ConvaTec Ltd) 1 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Zibor 3,500units/0.2ml solution for injection pre-filled syringes (ROVI Biotech Ltd) 10 pre-filled disposable injection 2 x 5 pre-filled syringes |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Suprasorb H dressing (adhesive) 14cm x 14cm square (Vernon-Carus Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Versiva dressing 14cm x 14cm square (ConvaTec Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Zibor 2,500units/0.2ml solution for injection pre-filled syringes (Amdipharm) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Ultec Pro adhesive dressing 14cm x 14cm square (Tyco Healthcare) 1 dressing |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Olanzapine 10mg powder for solution for injection vials |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Matrifen 75micrograms/hour transdermal patches (CST Pharma Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Virgan 0.15% eye gel (CST Pharma Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Matrifen 50micrograms/hour transdermal patches (CST Pharma Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Virgan 0.15% eye gel (CST Pharma Ltd) 5 gram |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Matrifen 25micrograms/hour transdermal patches (CST Pharma Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Matrifen 100micrograms/hour transdermal patches (CST Pharma Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Matrifen 25micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Dovonex 50micrograms/g ointment (Mawdsley-Brooks & Company Ltd) 30 gram |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Dovonex 50micrograms/g ointment (Mawdsley-Brooks & Company Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Argipressin 20units/1ml solution for injection ampoules (AOP Orphan Ltd) 10 ampoule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Keromask masking cream mixer rose (Bellava Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Keromask masking cream mixer rose (Bellava Ltd) 15 ml |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Argipressin 20units/1ml solution for injection ampoules (AOP Orphan Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Matrifen 100micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Matrifen 75micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Matrifen 50micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Product containing precisely nifedipine 5 milligram/1 each conventional release oral capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Product containing precisely nifedipine 10 milligram/1 each conventional release oral capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 5mg capsules (Kent Pharma (UK) Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 5mg capsules (A A H Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 5mg capsules (Unichem Plc) 84 capsule 6 x 14 capsules |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 10mg capsules (Viatris UK Healthcare Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Adalat 10mg capsules (PI) (Waymade Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 10mg capsules (Approved Prescription Services) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Adalat 10mg capsules (Doncaster Pharmaceuticals Ltd) 90 capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Adalat 10mg capsules (Mawdsley-Brooks & Company Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Gammaplex 10% 10g/100ml solution for infusion bottles (Bio Products Laboratory Ltd) 1 bottle |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 10mg capsules (The Boots Company) 84 capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 5mg capsules 90 capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 10mg capsules (Relonchem Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 5mg capsules (IVAX Pharmaceuticals UK Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Adalat 10mg capsules (PI) (Waymade Ltd) 50 capsule 5 x 10 capsules |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Adalat 10mg capsules (Sigma Pharmaceuticals Plc) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Adalat 5 capsules (Bayer Plc) 90 capsule 9 x 10 capsules |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 5mg capsules (Co-Pharma Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 5mg capsules (The Boots Company) 84 capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 10mg capsules (Kent Pharma (UK) Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 10mg capsules (IVAX Pharmaceuticals UK Ltd) 84 capsule 6 x 14 capsules |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 5mg capsules (Sigma Pharmaceuticals Plc) 84 capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 5mg capsules (Waymade Healthcare Plc) 84 capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Adalat 10mg capsules (Mawdsley-Brooks & Company Ltd) 50 capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 10mg capsules (The Boots Company) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 10mg capsules (Alpharma Limited) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 10mg capsules (Waymade Healthcare Plc) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 5mg capsules (Viatris UK Healthcare Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 10mg capsules 90 capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 10mg capsules (Unichem Plc) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Angiopine 10 capsules (Ashbourne Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Adalat 10mg capsules (Bayer Plc) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Adalat 10mg capsules (Doncaster Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 10mg capsules (IVAX Pharmaceuticals UK Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
| Nifedipine 10mg capsules 100 capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|